C
C.H.J. van Eijck
Researcher at Erasmus University Rotterdam
Publications - 121
Citations - 5081
C.H.J. van Eijck is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Pancreatic cancer & Somatostatin. The author has an hindex of 33, co-authored 121 publications receiving 4301 citations. Previous affiliations of C.H.J. van Eijck include University of Amsterdam.
Papers
More filters
Journal ArticleDOI
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate
Dirk Jan Kwekkeboom,Willem H. Bakker,Boen Liong Kam,Jaap J.M. Teunissen,P. P. M. Kooij,W. W. de Herder,Richard A Feelders,C.H.J. van Eijck,M. de Jong,Ananthachari Srinivasan,Jack L. Erion,E. P. Krenning +11 more
TL;DR: In this article, the effects of (177)Lu-octreotate therapy were studied in 35 patients with neuroendocrine gastro-entero-pancreatic (GEP) tumours who underwent follow-up for 3-6 months after receiving their final dose.
Journal ArticleDOI
Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.
Eva Versteijne,J.A. Vogel,Marc G. Besselink,O.R.C. Busch,Johanna W. Wilmink,Joost G. Daams,C.H.J. van Eijck,B. Groot Koerkamp,Coen R.N. Rasch,G. van Tienhoven +9 more
TL;DR: The aim of this study was to report survival by intention to treat in a comparison of upfront surgery versus neoadjuvant treatment in resectables or borderline resectable pancreatic cancer.
Journal ArticleDOI
Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality
R. F. de Wilde,Marc G. Besselink,I. van der Tweel,I.H.J.T. de Hingh,C.H.J. van Eijck,Cornelis H. C. Dejong,Robert J. Porte,D. J. Gouma,O.R.C. Busch,I. Q. Molenaar +9 more
TL;DR: Analysis of changes in hospital volumes and in‐hospital mortality after PD in the Netherlands between 2004 and 2009 found that nationwide centralization of pancreaticoduodenectomy affected mortality.
Journal ArticleDOI
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy.
Eric P. Krenning,M. de Jong,P. P. M. Kooij,Wouter A.P. Breeman,Willem H. Bakker,W. W. de Herder,C.H.J. van Eijck,Dirk Jan Kwekkeboom,F. Jamar,S. Pauwels,Roelf Valkema +10 more
TL;DR: End-stage patients with mostly neuroendocrine progressing tumours treated with [111In-DTPA0]octreotide showed promising beneficial effects on clinical symptoms, hormone production and tumour proliferation and PRRT is feasible, also with 111In as radionuclide.
Journal ArticleDOI
Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer.
A.Y. de Kanter,C.H.J. van Eijck,A.N. van Geel,R. H. Kruijt,S. C. Henzen,M. A. Paul,A. M. M. Eggermont,T. Wiggers +7 more
TL;DR: This study investigated whether ultrasonographically guided fine‐needle aspiration cytology of the axillary lymph nodes in clinically node‐negative patients was an accurate staging procedure to select patients for sentinel node biopsy.